|
|
|
Roche
Acquires BioVeris for $600M |
|
|
| April
4, 2007--Roche
will acquire BioVeris Corporation for approximately $600
million, allowing Roche Diagnostics to expand its
immunochemistry business from the human diagnostics field
into new market segments. By acquiring BioVeris, Roche
will own the complete patent estate of the
electrochemiluminescence technology that is already
deployed in its Elecsys immunochemistry product line. Roche
|
|
|
|
|
|
|
